Industry: Healthcare | Lastest Edition: March 2, 2026 | No of Pages: 141 | No. of Tables: 107 | No. of Figures: 52 | Format: PDF | Report Code : HC1258
The U.S. Dialysis Market size was valued at USD 23.92 billion in 2024 and is expected to reach USD 27.14 billion by 2025. Looking ahead, the industry is projected to expand significantly, reaching USD 37.09 billion by 2030, registering a CAGR of 6.45% from 2025 to 2030.
The U.S. dialysis market is witnessing robust growth due to the increasing prevalence of chronic kidney disease and related comorbidities such as diabetes and hypertension. Advances in dialysis technology, including more efficient hemodialysis and peritoneal dialysis systems, are improving patient outcomes and comfort. Moreover, growing adoption of home-based dialysis therapies, coupled with supportive government initiatives and improved healthcare infrastructure, is driving wider access. With continuous innovation, the U.S. dialysis industry is moving toward more patient-centric and technologically advanced care solutions.
The dialysis market in U.S. is witnessing strong growth in home-based and portable dialysis therapies. Portable dialysis machines and user-friendly systems allow patients to conduct treatments at home, offering greater flexibility and reducing the need for frequent hospital visits. This trend aligns with the healthcare sector’s emphasis on patient-centric care and chronic disease management.
Benefits such as lower treatment costs, enhanced convenience, and improved quality of life are encouraging adoption. Additionally, supportive insurance policies and training programs for home dialysis are making this shift more accessible. Integration of remote monitoring and digital health platforms further ensures treatment accuracy and patient safety, strengthening demand for home and portable dialysis solutions across the U.S.
Chronic kidney disease (CKD) continues to be a major health concern in the U.S., driven by aging populations and lifestyle-related conditions such as diabetes and hypertension. As more individuals progress to end-stage renal disease, the need for consistent dialysis treatment is growing, driving demand across hospitals, clinics, and specialized dialysis centers. Increased screening, early diagnosis, and patient awareness are enabling timely treatment, further supporting U.S. dialysis market growth. Healthcare providers are also investing in advanced dialysis technologies to improve efficiency and patient outcomes. These factors collectively accelerate the adoption of dialysis solutions, establishing CKD prevalence as a key driver of the U.S. dialysis industry.
The cost of dialysis treatment and equipment continues to pose a restraint in the U.S. market. Setting up dialysis centers requires significant capital investment in machinery, infrastructure, and trained medical staff. Recurring costs for consumables, maintenance, and patient monitoring increase the financial burden. Even with insurance coverage, patients may face high out-of-pocket expenses, particularly for home-based or advanced systems. These financial constraints can limit access in certain regions, particularly rural or underserved areas. Smaller healthcare providers may also struggle to invest in cutting-edge technologies, preventing widespread adoption of modern dialysis solutions and slowing overall market growth.
Digital health and connected dialysis technologies are creating new opportunities in the U.S. market. Remote monitoring, telehealth consultations, and data-driven analytics enable continuous supervision and personalized treatment adjustments. Smart dialysis machines with connectivity features allow real-time performance tracking and early detection of complications. Home-based dialysis adoption, supported by digital platforms, increases patient convenience and reduces hospital dependency. The growing focus on patient-centric care, combined with healthcare digitization initiatives, encourages manufacturers to develop intelligent, user-friendly dialysis systems. These innovations are expected to expand market reach, improve patient management, and enhance overall treatment outcomes in the dialysis market in U.S.
The market players operating in the U.S. dialysis industry include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., U.S. Renal Care, Inc., Nipro Corporation, B. Braun, Asahi Kasei Corporation, Becton, Dickinson and Company, Nikkiso Co. Ltd., Toray Medical Co., Ltd., Outset Medical, Inc., Satellite Healthcare, Terumo Corporation.
By Modality
Hemodialysis (HD)
Hemodialysis Machines
In-center HD
Home HD
Water Treatment Systems
Central water-disinfection units
Point-of-use/portable systems
Ancillary/Other HD Equipment
UF/ultrafiltration pumps
Dialysis chairs/beds
Disinfection/sterilization units
Monitoring & data-capture hardware
HD Consumables & Supplies
Dialyzers
Bloodlines & Tubing Sets
Dialysis Fluids / Concentrates
Vascular Access Products
Other HD Consumables & Accessories
HD Aftermarket Services
Repair & Maintenance
Installation & Commissioning
Training & Technical Support
Peritoneal Dialysis (PD)
PD Cyclers / Automated PD Machines
Ancillary PD Equipment
PD Consumables & Supplies
PD Dialysis Solutions
PD Catheters & Access Systems
Transfer Sets & Tubing
Other PD Supplies / Accessories
PD Aftermarket Services
Repair & Maintenance (Cyclers & Heaters)
Installation & Commissioning
Training & Technical Support
Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers
U.S. Renal Care, Inc.
Nipro Corporation
B Braun
Asahi Kasei Corporation
Becton, Dickinson and Company
Nikkiso Co. Ltd.
Toray Medical Co, Ltd.
Outset Medical, Inc.
Satellite Healthcare
Terumo Corporation
JMS Co. Ltd.
W. L. Gore & Associates, Inc.
Quanta Dialysis Technologies Ltd.
|
Parameters |
Details |
|
Market Size in 2025 |
USD 27.14 Billion |
|
Revenue Forecast in 2030 |
USD 37.09 Billion |
|
Growth Rate |
CAGR of 6.45% from 2025 to 2030 |
|
Analysis Period |
2024–2030 |
|
Base Year Considered |
2024 |
|
Forecast Period |
2025–2030 |
|
Market Size Estimation |
Billion (USD) |
|
Growth Factors |
|
|
Companies Profiled |
15 |
|
Market Share |
Available for 10 companies |
|
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
|
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |